Welcome!
Avantor Inc
Sector Focus
Biomedical, life science sectors in focus as Biopolis turns 20; CapitaLand revives Science Park Drive
“We spend a lot of effort encouraging many companies to use Singapore as a base, and also try to leverage our investment and R&D.”
August 10, 2023
Global stocks
Avantor: Underperforming pharma play but financial ratios remain healthy
Avantor is the global provider of mission-critical products and services to customers including the biopharma sector.
June 23, 2023
Global stocks
Navigating a chaotic year
The Edge Singapore’s 2022 virtual global portfolio returned -9.8% for the period of Feb 7, 2022, to Jan 13, 2023.
January 23, 2023
Global stocks
Avantor: Integrated biopharma vanguard
The company’s one-year total return was –41.4% although its financials were mostly intact.
January 23, 2023
Global stocks
Standing pat, staying put
Our 2022 portfolio lost 11.8% in the four-month period from Feb 7 to June 17, with eight losers in the portfolio.
June 24, 2022
Global stocks
Avantor: Key play for investors seeking value and biotechnology exposure
New York-listed Avantor Inc was among the underperformers in our portfolio for the four-month period, with a 18.0% loss.
June 24, 2022
Global stocks
Avantor: Driven by Covid vaccine, demand from biopharma
Strong margins and attractive yields give Avantor a competitive edge.
February 03, 2022
Global stocks
Our top 10 global stocks for 2022
Here’s our 10 global stock picks for this year.
February 03, 2022